Skip to main content
Steven Sparagana, MD, Child Neurology, Dallas, TX

StevenP.SparaganaMD

Child Neurology Dallas, TX

Neurodevelopmental Disabilities

Assistant Professor, Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Southwestern Medical School

Overview of Dr. Sparagana

Dr. Steven Sparagana is a Child Neurologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas and Scottish Rite for Children. He received his medical degree from The University of Texas Health Science Center at San Antonio and has been in practice 28 years. He is one of 37 doctors at Children's Medical Center Dallas and one of 3 doctors at Scottish Rite for Children who specialize in Child Neurology. He has more than 50 publications and over 500 citings.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Clinical Neurophysiology, 1997 - 1998
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Child Neurology, 1991 - 1994
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1989 - 1990
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 1989

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1994 - 2026
  • MT State Medical License
    MT State Medical License 1993 - 2025
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology
  • American Board of Psychiatry and Neurology Neurodevelopmental Disabilities

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The Role of the TSC Alliance in Advancing Therapy Development: A Patient Organization Perspective
    The Role of the TSC Alliance in Advancing Therapy Development: A Patient Organization PerspectiveAugust 8th, 2024